中药板块11月3日涨0.38%，维康药业领涨，主力资金净流出8601.68万元

Market Overview - The Chinese medicine sector rose by 0.38% on November 3, with Weikang Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Top Gainers in Chinese Medicine Sector - Weikang Pharmaceutical (300878) closed at 27.20, up 9.19%, with a trading volume of 117,800 shares and a transaction value of 326 million [1] - Zhongsheng Pharmaceutical (002317) closed at 20.19, up 4.50%, with a trading volume of 1,005,900 shares and a transaction value of 2.014 billion [1] - Zhenbaodao (603567) closed at 11.69, up 3.45%, with a trading volume of 155,200 shares and a transaction value of 182 million [1] Top Losers in Chinese Medicine Sector - Wanbangde (002082) closed at 15.00, down 5.18%, with a trading volume of 318,200 shares and a transaction value of 488 million [2] - Qidi Pharmaceutical (000590) closed at 12.13, down 3.42%, with a trading volume of 95,600 shares and a transaction value of 116 million [2] - Fangsheng Pharmaceutical (603998) closed at 12.09, down 1.63%, with a trading volume of 132,500 shares and a transaction value of 161 million [2] Capital Flow Analysis - The Chinese medicine sector experienced a net outflow of 86.02 million from institutional investors and a net outflow of 135 million from speculative funds, while retail investors saw a net inflow of 221 million [2][3] - Notable net inflows from institutional investors included Yunnan Baiyao with 22.51 million and Darentang with 40.67 million [3] Individual Stock Capital Flow - Zhongsheng Pharmaceutical had a net outflow of 50.68 million from institutional investors, while retail investors saw a net outflow of 18.80 million [3] - Darentang experienced a net inflow of 40.67 million from institutional investors, with a net outflow of 52.10 million from speculative funds [3] - Tielong Pharmaceutical had a net inflow of 5.33 million from institutional investors, with a significant net outflow of 15.53 million from speculative funds [3]